{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:21:13Z","timestamp":1758759673429,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.thromres.2023.12.017","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T18:48:08Z","timestamp":1704307688000},"page":"113-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessing uptake of the core outcome set in clinical trials for immune thrombocytopenia: A cross-sectional analysis"],"prefix":"10.1016","volume":"234","author":[{"given":"Mahad","family":"Chaudhry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Magana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaelyn","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Magee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Griffin","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia Ito","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Vassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.thromres.2023.12.017_bb0005","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00277-020-04257-2","article-title":"Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center","volume":"99","author":"Jaime-P\u00e9rez","year":"2020","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.thromres.2023.12.017_bb0010","article-title":"Primary immune thrombocytopenia: novel insights into pathophysiology and disease management","volume":"10","author":"Singh","year":"2021","journal-title":"J. Clin. Med. Res. [Internet]"},{"issue":"2","key":"10.1016\/j.thromres.2023.12.017_bb0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13696998.2019.1669329","article-title":"Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis","volume":"23","author":"Weycker","year":"2020","journal-title":"J. Med. Econ."},{"issue":"13","key":"10.1016\/j.thromres.2023.12.017_bb0020","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials - the gold standard for effectiveness research: study design: randomised controlled trials","volume":"125","author":"Hariton","year":"2018","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.thromres.2023.12.017_bb0025","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/aogs.13309","article-title":"A simplified guide to randomized controlled trials","volume":"97","author":"Bhide","year":"2018","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.017_bb0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3324\/haematol.11582","article-title":"Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature","volume":"93","author":"Ruggeri","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2023.12.017_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1745-6215-8-39","article-title":"Standardising outcomes for clinical trials and systematic reviews","volume":"8","author":"Clarke","year":"2007","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.thromres.2023.12.017_bb0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1191\/0962280205sm415oa","article-title":"Outcome selection bias in meta-analysis","volume":"14","author":"Williamson","year":"2005","journal-title":"Stat. Methods Med. Res."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.017_bb0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwj069","article-title":"Bias in clinical intervention research","volume":"163","author":"Gluud","year":"2006","journal-title":"Am. J. Epidemiol."},{"issue":"11","key":"10.1016\/j.thromres.2023.12.017_bb0050","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.12.017_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jclinepi.2020.09.029","article-title":"A systematic review finds Core Outcome Set uptake varies widely across different areas of health","volume":"129","author":"Hughes","year":"2021","journal-title":"J. Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.017_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med."},{"key":"10.1016\/j.thromres.2023.12.017_bb0070","article-title":"A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis","volume":"357","author":"Kirkham","year":"2017","journal-title":"BMJ"},{"author":"Magee","key":"10.1016\/j.thromres.2023.12.017_bb0075"},{"issue":"1","key":"10.1016\/j.thromres.2023.12.017_bb0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.thromres.2023.12.017_bb0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2007.06635.x","article-title":"The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP","volume":"138","author":"Page","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"14","key":"10.1016\/j.thromres.2023.12.017_bb0095","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2012-07-442392","article-title":"Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group","volume":"121","author":"Rodeghiero","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2023.12.017_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2141.2010.08562.x","article-title":"ITP: a historical perspective","volume":"153","author":"Stasi","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.thromres.2023.12.017_bb0105","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/jth.15366","article-title":"Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: communication from the ISTH SSC subcommittee on platelet immunology","volume":"19","author":"Al-Samkari","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2023.12.017_bb0110","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1111\/jth.12432","article-title":"Effect of platelet count on platelet aggregation measured with impedance aggregometry (MultiplateTM analyzer) and with light transmission aggregometry","volume":"11","author":"Femia","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.017_bb0115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1182\/asheducation-2017.1.400","article-title":"Management of newly diagnosed immune thrombocytopenia: can we change outcomes?","volume":"2017","author":"Neunert","year":"2017","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"5","key":"10.1016\/j.thromres.2023.12.017_bb0120","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00277-022-04786-y","article-title":"Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives","volume":"101","author":"Vianelli","year":"2022","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.thromres.2023.12.017_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12185-014-1706-8","article-title":"Application of ITP-BAT bleeding score in clinical practice","volume":"101","author":"Kumar","year":"2015","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.017_bb0130","first-page":"214","article-title":"Consensus of Chinese experts on diagnosis and treatment of adult primary immune thrombocytopenia","volume":"32","author":"Hemostasis and Thrombosis Group","year":"2011","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.thromres.2023.12.017_bb0135","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/16078454.2021.1978753","article-title":"Comparative study between two bleeding grading systems of immune thrombocytopenia purpura","volume":"26","author":"Chen","year":"2021","journal-title":"Hematology"},{"key":"10.1016\/j.thromres.2023.12.017_bb0140","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620910790","article-title":"Comparative study of the clinical application of 2 bleeding grading systems for pregnant women with immune thrombocytopenia","volume":"26","author":"Huang","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"9","key":"10.1016\/j.thromres.2023.12.017_bb0145","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/jpepsy\/jsn038","article-title":"Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology","volume":"33","author":"Palermo","year":"2008","journal-title":"J. Pediatr. Psychol."},{"issue":"23","key":"10.1016\/j.thromres.2023.12.017_bb0150","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv."},{"issue":"22","key":"10.1016\/j.thromres.2023.12.017_bb0155","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2023.12.017_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-7525-5-11","article-title":"A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation","volume":"5","author":"Mathias","year":"2007","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.thromres.2023.12.017_bb0165","article-title":"Impact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analyses","volume":"356","author":"Baudard","year":"2017","journal-title":"BMJ"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:52:41Z","timestamp":1758736361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823003729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":31,"alternative-id":["S0049384823003729"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.12.017","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing uptake of the core outcome set in clinical trials for immune thrombocytopenia: A cross-sectional analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}